TREM2 and Alzheimer disease: These data suggest that both APOE E4 and TREM2 R47H variants are associated with a dampened ARM response to beta-amyloid plaques, raising the possibility that APOE and TREM2 risk genotypes may confer risk for AD by down modulation of the ARM response.